Stocks slide as jobs and wages rise spark inflation fears
Investors pushed stocks and bonds lower after record oil and surprisingly strong July wage data. The Labor Department reported hourly earnings at 16.13, the highest this year, fueling expectations the Federal Reserve may keep raising rates. Dow fell 52.07 to 10,558.03, S&P 500 down 9.44 to 1,226.42, Nasdaq off 13.41 to 2,177.91. Bond yields climbed, dollar strengthened, gold slipped.
MENTIONED IN THIS ARTICLE
Dow Jones
Dow Industrials
Dow Transportation
Dow Utilities
Nyse Composite
S&p MidCap
Russell
Wilshire
Stock Exchange
AMEX
Onse
DoverMot
IntriCon
InPlay
Unova
Bellind
Beaconp
CedarSh
IMI
Provalis
AllisChn
ProvdCom
RockTen
Vicon
Ascie
Reviow
Memry
OnAssign
CANTV
Cognitin
ElectEnera
Oxfordinds
Managist
ParagonTe
Tesoro
Delphi Pfa
Caglea
PW Eagle
Delphi
Ablest
ImpaxLab II
Cohen&St
Ugrdn
Cabg Mdn
Chiquiawt
IntelliCk
HudsonTch
Tredgar
SbdCp
Microsoft
TainSemi
GenElec
iShJa
Cisco
Pfizer
iShRi
Oracle
Motorola
Djia Diam
JDS Umph
Dresserr N
KvaxCps
Baidun
Citigrp
NetwkAp
ExxonMbl
SP F
Hewlettp
NY 2.92 44 14 66.33 -1.22 +8.6 HomeDp NY
AEP NY
IngerRd NY
Aramark NY
Intel Nasd
Bb&tcp NY
IBM NY
BakrHu NY
JohnJn NY
Kr NY
LowesCos NY
Chevrons NY
Marathon NY
CitzComm NY
Microsoft Nash
Cocac NY
Oracle Nasd
Daimirc NY
Penne NY
Dellinc Nash
Disne NY
Pepsi Pfizer NY
DomRes NY
Praxair NY
DuPont NY
DukeEgg NY
RexStrs NY
eBays
SearsHidgs Nasd
EmrsnEl NY
Teminsny
ExxonMbl NY
FC Nasd
UPS
Ford NY
US Steel NY
GenElec NY
VerizonCm NY
GnMett
WalMart NY
Australia
Britain
Japan
Mexico
U.S
ICAA
Wsha P LV
Cox
American Funds
Incoa P MP
Pera P
WGA
Vanguard Idx
Bala P
Wadsll LV
Wellin
Divint IL E
Eq Inc IP
Lipper, Inc
Raat
Carl Ies
AK Steel
At&t
AbtLab
AberFite
Accenture
AMD
AttCmpt
Alcoa
Alltel
Altria
AmExp
AmintGp If
AnalogDev
Anheust
ArchDan
Avaya Avon
BkofAms
Beatrams
BellSouth
BestBuys
BostonSci BrMySq
CVS Cos
Calpine Carnival
Cendant
Centex
ChesEng
Delphi DeltaAir
Disney
DowChmn
DuPont
DukeEgg
Dynegy
Etrade
EMC Cp
Elan
EDS
QOHPT
ExxonMb
Fanniem
Fordm
Friedbr
Gap
GenEiec
GnMotr
Gerdaus
Goldman
Heclam
Hewlett P
IBM
Libtyma
Lilly
LowesCos
Lucent
MBNA
MEMC
Medtric
Merck
MerrillLyn
MetrisCos
Micront
MorgStan
Noilvarco
Newmtm
Newscpa N
NokiaCo
Nordstrm
NortelNet
PaulShoe
Penney
PepsiCo
ProctGam
Providian
PulttHm
QwestCm
RelingtEn
SBC Com
St Paul Trav
Sara Lee
Schergp
Schimb
Schwab
Seagate T
SilenGorth
Solectra
Spratfon
Suncorg
Texinst
TollBross
Transoen
Tycointl
UtdMicro
ValeroE's
Vise i
Wachovia
WalMart
WA Muli
WellsFrgo
Xerox
New York
Wall Street
Labor Department
New York Mercantile Exchange
Standard
Steven Goldman
Weeden & Co
Greenwich
Federal Reserve
Fed
Dow
S&p
Joseph V. Battipaglia
Ryan Beck & Co
SEC criticizes Scrushy judge in civil suit filing
The SEC challenges U.S. District Judge Karen Bowdre in the Scrushy HealthSouth fraud case, calling several rulings hard to understand while pressing a civil action seeking $785 million in fines and restitution. HealthSouth settled $100 million of the suit. the SEC seeks further penalties and interest.
MENTIONED IN THIS ARTICLE
Birmingham
Ala
Richard Scrushy
HealthSouth Corp
Securities and Exchange Commission
Scrushy
SEC
U.S
Karen Bowdre
Bowdre
Agency
HealthSouth
Justice Department
Inge Johnson
Boom in second homes reshapes North Carolina markets
On a western tip hillside in North Carolina, real estate agent Joey Reid showcases Black Rock Falls, a new upscale vacation development with 10 foot ceilings and mountain views priced 300000 to 500000. The project taps a national surge as baby boomers seek vacation or retirement homes, fueled by low rates and strong equity driving buyers from Georgia, Florida, and beyond.
MENTIONED IN THIS ARTICLE
Arble
N.C
North Carolina
Joey Reid
Black Rock Falls
Reid
Charlotte
Marble
Murphy
Oregon
San Francisco Bay Area
Ashland
Scenic
Paonia
Colo
Snowmass
Aspen
Carbondale
Ron Rowell
Colorado
National Association of Realtors
Jeff Lyons
Realestate.com
Merck executive clashes with Vioxx plaintiff attorney in trial
In a Texas courtroom, former Merck top scientist Dr. Alan Nies sparred with plaintiff attorney Mark Lanier over a 1996 Vioxx development plan that warned of revenue losses if Pfizer’s Celebrex outran Merck. The case stems from Robert Ernst’s death after eight months on Vioxx.
MENTIONED IN THIS ARTICLE
Merck
Vioxx
Angleton
Pfizer
Plaintiff
Mark Lanier
Lanier
Nies
Robert Ernst
Also Mentioned on This Page
the Market IN Review
Nyse
Dainty Dow
Jones